ABERA — Abera Bioscience AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK66.53m
- SEK63.21m
Annual cashflow statement for Abera Bioscience AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.47 | -3.64 | -9.16 | -19.4 | -16.8 |
| Changes in Working Capital | -0.519 | 0.893 | -0.516 | -0.299 | -0.91 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.99 | -2.75 | -9.68 | -19.7 | -17.7 |
| Financing Cash Flow Items | — | — | -2.37 | -0.892 | -0.008 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.14 | 1 | 20.7 | 23.2 | 5.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.15 | -1.75 | 11 | 3.48 | -12.1 |